These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7526171)

  • 1. Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks.
    Noviello E; Aluigi MG; Cimoli G; Rovini E; Mazzoni A; Parodi S; De Sessa F; Russo P
    Mutat Res; 1994 Nov; 311(1):21-9. PubMed ID: 7526171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
    Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
    Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3).
    Cimoli G; Valenti M; Noviello E; Parodi S; Mazzoni A; Rovini E; De Sessa F; Russo P
    J Cancer Res Clin Oncol; 1995; 121(3):155-63. PubMed ID: 7713987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
    Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
    Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II.
    Darroudi F; Natarajan AT
    Mutat Res; 1989 Jun; 212(2):137-48. PubMed ID: 2543922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
    Orengo G; Noviello E; Cimoli G; Pagnan G; Parodi S; Venturini M; Conte P; Schenone F; Conzi G; Russo P
    Jpn J Cancer Res; 1992 Nov; 83(11):1132-6. PubMed ID: 1336489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.
    Alaoui Jamali MA; Yin MB; Mazzoni A; Bankusli I; Rustum YM
    Cancer Chemother Pharmacol; 1989; 25(2):77-83. PubMed ID: 2598402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53.
    Vikhanskaya F; Clerico L; Valenti M; Stanzione MS; Broggini M; Parodi S; Russo P
    Int J Cancer; 1997 Jul; 72(1):155-9. PubMed ID: 9212237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circumvention of atypical multidrug resistance with tumor necrosis factor.
    Cimoli G; Valenti M; Parodi S; De Sessa F; Russo P
    Jpn J Cancer Res; 1994 Feb; 85(2):135-8. PubMed ID: 8144394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytological characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. II. Induction of sister-chromatid exchanges and chromosomal aberrations by X-rays and UV-irradiation and their modulation by inhibitors of poly(ADP-ribose) synthetase and alpha-polymerase.
    Darroudi F; Natarajan AT
    Mutat Res; 1987 Mar; 177(1):149-60. PubMed ID: 3102955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sister chromatid exchanges and DNA topoisomerase II inhibitors: effect of low concentrations of etoposide (VP-16) in ataxia telangiectasia lymphoblastoid cell lines.
    Fantini C; Vernole P; Tedeschi B; Caporossi D
    Mutat Res; 1998 Jan; 412(1):1-7. PubMed ID: 9508359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors.
    Binaschi M; Capranico G; De Isabella P; Mariani M; Supino R; Tinelli S; Zunino F
    Int J Cancer; 1990 Feb; 45(2):347-52. PubMed ID: 2154411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant interferon-alpha on streptonigrin-induced chromosome aberrations and sister-chromatid exchanges in hamster cells.
    Bolzán AD; Lacunza E; Bianchi MS
    Mutat Res; 2003 Jan; 522(1-2):127-34. PubMed ID: 12517418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of topoisomerase II: structure-activity relationships and mechanism of action of podophyllin congeners.
    Long BH; Stringfellow DA
    Adv Enzyme Regul; 1988; 27():223-56. PubMed ID: 2854948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines.
    Chatterjee S; Trivedi D; Petzold SJ; Berger NA
    Cancer Res; 1990 May; 50(9):2713-8. PubMed ID: 2328496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis.
    Voigt W; Matsui S; Yin MB; Burhans WC; Minderman H; Rustum YM
    Anticancer Res; 1998; 18(5A):3499-505. PubMed ID: 9858931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells.
    de Tinguy-Moreaud E; Pourquier P; Montaudon D; Robert J
    Anticancer Res; 1994; 14(1A):99-103. PubMed ID: 8166463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells.
    Suzuki H; Ikeda T; Yamagishi T; Nakaike S; Nakane S; Ohsawa M
    Mutat Res; 1995 May; 328(2):151-61. PubMed ID: 7739599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal aberrations and genomic instability induced by topoisomerase-targeted antitumour drugs.
    Degrassi F; Fiore M; Palitti F
    Curr Med Chem Anticancer Agents; 2004 Jul; 4(4):317-25. PubMed ID: 15281904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.